Integra LifeSciences Statistics Share Statistics Integra LifeSciences has 77.91M
shares outstanding. The number of shares has increased by 0.17%
in one year.
Shares Outstanding 77.91M Shares Change (YoY) 0.17% Shares Change (QoQ) 0.64% Owned by Institutions (%) 96.12% Shares Floating 65.88M Failed to Deliver (FTD) Shares 3,755 FTD / Avg. Volume 0.29%
Short Selling Information The latest short interest is 6.47M, so 8.32% of the outstanding
shares have been sold short.
Short Interest 6.47M Short % of Shares Out 8.32% Short % of Float 13.55% Short Ratio (days to cover) 7.02
Valuation Ratios The PE ratio is -251.52 and the forward
PE ratio is 5.36.
Integra LifeSciences's PEG ratio is
2.28.
PE Ratio -251.52 Forward PE 5.36 PS Ratio 1.08 Forward PS 0.6 PB Ratio 1.13 P/FCF Ratio 69.96 PEG Ratio 2.28
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Integra LifeSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.17,
with a Debt / Equity ratio of 1.28.
Current Ratio 1.17 Quick Ratio 0.71 Debt / Equity 1.28 Debt / EBITDA 10.27 Debt / FCF 79.5 Interest Coverage 0.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $366.36K Profits Per Employee $-1.58K Employee Count 4,396 Asset Turnover 0.4 Inventory Turnover 1.7
Taxes Income Tax -11.29M Effective Tax Rate 61.92%
Stock Price Statistics The stock price has increased by -40.11% in the
last 52 weeks. The beta is 1.17, so Integra LifeSciences's
price volatility has been higher than the market average.
Beta 1.17 52-Week Price Change -40.11% 50-Day Moving Average 12.59 200-Day Moving Average 19.01 Relative Strength Index (RSI) 53.53 Average Volume (20 Days) 1,290,764
Income Statement In the last 12 months, Integra LifeSciences had revenue of 1.61B
and earned -6.94M
in profits. Earnings per share was -0.09.
Revenue 1.61B Gross Profit 882.06M Operating Income 28.41M Net Income -6.94M EBITDA 193.29M EBIT 52.4M Earnings Per Share (EPS) -0.09
Full Income Statement Balance Sheet The company has 246.38M in cash and 1.98B in
debt, giving a net cash position of -1.74B.
Cash & Cash Equivalents 246.38M Total Debt 1.98B Net Cash -1.74B Retained Earnings 939.91M Total Assets 3.67B Working Capital 213.02M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 129.38M
and capital expenditures -104.42M, giving a free cash flow of 24.96M.
Operating Cash Flow 129.38M Capital Expenditures -104.42M Free Cash Flow 24.96M FCF Per Share 0.32
Full Cash Flow Statement Margins Gross margin is 54.77%, with operating and profit margins of 1.76% and -0.43%.
Gross Margin 54.77% Operating Margin 1.76% Pretax Margin -1.13% Profit Margin -0.43% EBITDA Margin 12% EBIT Margin 1.76% FCF Margin 1.55%
Dividends & Yields IART does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IART is $19,
which is 49% higher than the current price. The consensus rating is "Hold".
Price Target $19 Price Target Difference 49% Analyst Consensus Hold Analyst Count 9
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 4, 2017. It was a
forward
split with a ratio of 2:1.
Last Split Date Jan 4, 2017 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 0.44 Piotroski F-Score 5
